Displaying 1 - 7 of 7
| Active Ingredient | DOBUTAMINE |
| Therapeutic Class | BETA ADRENERGIC AGONIST |
| Indications | Inotropic support in infarction, cardiac surgery, cardiomyopathies, septic shock, cardiogenic shock. |
| Caution | Dose-related increases in heart rate and blood pressure, ectopic beats, angina or chest pain, and palpitations; dosage should be reduced or temporarily stopped if they occur. |
| Dose Range | i.v. infusion: 2.5-10 micrograms/kg/minute, adjusted according to response, alternatively 0.5-40 micrograms/kg/minute. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DOPAMINE |
| Therapeutic Class | BETA ADRENERGIC AGONIST |
| Indications | Cardiogenic shock in myocardial infarction. |
| Caution | Correct hypovolemia, CVP monitoring advisable. Extravasation, may cause necrosis. Recommended that a large central vein be used for infusion. Nausea, peripheral vasoconstriction, tachy cardia. |
| Dose Range | i.v. infusion: 2-5mcg/kg/minute, increasing if necessary |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ISOPRENALINE |
| Therapeutic Class | BETA ADRENERGIC AGONIST |
| Indications | Sustained release preparation useful in patients with chronic sinus brady cardia, i.v. infusion for acute sinus brady cardia, heart block. |
| Caution | Tremor, tachy cardia, urinary retention; insomnia. Use with caution in heart disease. |
| Dose Range | Adult: i.v. infusion; 0.5-10mcg/minute. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ADRENALINE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | Acute bronchospasm. Emergency treatment of asthma and anaphylaxis, cardiac arrest. |
| Caution | Cardiac arrhythmias, tachycardia, tremor, anxiety . Avoid in the elderly and patients with heart disease. |
| Dose Range | 0.5-1mg s.c. or i.m. |
| Drug Interactions | |
| Pregnancy | May reduce placental perfusion and cause tachycardia, cardiac irregularities, an More ... |
| Breast Feeding | Present in milk but unlikely to be harmful as poor oral bioavailability. |
| Active Ingredient | EPHEDRINE HYDROCHLORIDE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | Reversal of hypotension from spinal or epidural anaesthesia |
| Caution |
Anginal pain; anxiety; arrhythmias; flushing; headache; hypersalivation. |
| Dose Range | 3-6 mg every 3-4 minutes (max. p er dose 9 mg), adjusted according to response, injection solution to contain ephedrine hydrochloride 3 mg/ml; maximum 30 mg p er course. |
| Drug Interactions | |
| Pregnancy | Increased fetal heart rate has been reported. Use with caution during pregnancy. |
| Breast Feeding |
| Active Ingredient | NORADRENALINE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PSEUDOEPHEDRINE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | Symptomatic relief of nasal congestion. |
| Caution | Tachycardia, anxiety, restlessness, and insomnia. |
| Dose Range | Adults and children over 12 years: 60mg every 4-6 hours to a maximum of 4 doses in 24 hours; patients with renal dysfunction should have dose adjustments. Pediatric: 6-12 years: 30mg 3-4 times daily. |
| Drug Interactions | |
| Pregnancy | Pseudoephedrine should be avoided during pregnancy because of the severity of th More ... |
| Breast Feeding | May suppress lactation; avoid if lactation is not well established or if milk pr More ... |